Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 3
2001 1
2002 6
2003 7
2004 6
2005 6
2006 4
2007 3
2009 1
2010 4
2011 3
2013 1
2014 2
2015 1
2018 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Headache treatment after electroconvulsive treatment: a single-blinded trial comparator between eletriptan and paracetamol.
Kertesz DP, Trabekin O, Vanetik MS. Kertesz DP, et al. J ECT. 2015 Jun;31(2):105-9. doi: 10.1097/YCT.0000000000000179. J ECT. 2015. PMID: 25181019 Clinical Trial.
At 4 hours, none of the patients in the eletriptan group had any headaches, whereas in the paracetamol group, the VAS was 4.8 (5.1) (P = 0.120). The mean (SD) headache duration was 1.61 (1.09) hours in the eletriptan versus 3.55 (1.19) hours in the paracetamol group …
At 4 hours, none of the patients in the eletriptan group had any headaches, whereas in the paracetamol group, the VAS was 4.8 (5.1) ( …
Pharmacokinetics and tolerability of eletriptan hydrobromide in healthy Korean subjects.
Kim YK, Shin KH, Alderman J, Yu KS, Jang IJ, Lee S. Kim YK, et al. Drug Des Devel Ther. 2018 Feb 19;12:331-337. doi: 10.2147/DDDT.S149119. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 29497279 Free PMC article. Clinical Trial.
PURPOSE: This study aimed to evaluate the pharmacokinetic (PK) and tolerability profiles of eletriptan hydrobromide (eletriptan HBr), a selective 5-hydroxytryptamine (also known as serotonin) 1B/1D receptor agonist, in Koreans and compare the results to those observ …
PURPOSE: This study aimed to evaluate the pharmacokinetic (PK) and tolerability profiles of eletriptan hydrobromide (eletriptan …
Comparative efficacy of eletriptan and zolmitriptan in the acute treatment of migraine.
Steiner TJ, Diener HC, MacGregor EA, Schoenen J, Muirheads N, Sikes CR. Steiner TJ, et al. Cephalalgia. 2003 Dec;23(10):942-52. doi: 10.1046/j.1468-2982.2003.00617.x. Cephalalgia. 2003. PMID: 14984226 Clinical Trial.
This study continues the systematic series of active comparator trials in the eletriptan clinical development programme. In a multicentre double-blind, double-dummy, parallel-groups trial, 1587 outpatients with migraine by IHS criteria were randomised in a 3: 3 : 3: 1 rati …
This study continues the systematic series of active comparator trials in the eletriptan clinical development programme. In a multice …
Efficacy and safety of eletriptan 20 mg, 40 mg and 80 mg in Japanese migraineurs.
Eletriptan Steering Committee in Japan. Eletriptan Steering Committee in Japan. Cephalalgia. 2002 Jul;22(6):416-23. doi: 10.1046/j.1468-2982.2002.00372.x. Cephalalgia. 2002. PMID: 12133040 Clinical Trial.
Eletriptan had a statistically significant dose response for headache relief and pain-free response at 2 h post-dose (P=0.0011 and P=0.0291, respectively). ...Eletriptan was shown to be efficacious, safe, and well tolerated in Japanese migraineurs....
Eletriptan had a statistically significant dose response for headache relief and pain-free response at 2 h post-dose (P=0.0011 and P= …
Eletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack study.
Sandrini G, Färkkilä M, Burgess G, Forster E, Haughie S; Eletriptan Steering Committee. Sandrini G, et al. Neurology. 2002 Oct 22;59(8):1210-7. doi: 10.1212/wnl.59.8.1210. Neurology. 2002. PMID: 12391349 Clinical Trial.
METHODS: Patients with a history of migraine (n = 1,008) were randomly assigned to receive placebo, 40 mg of eletriptan, 80 mg of eletriptan, 50 mg of sumatriptan, or 100 mg of sumatriptan to treat up to three attacks. ...Eletriptan and sumatriptan were well …
METHODS: Patients with a history of migraine (n = 1,008) were randomly assigned to receive placebo, 40 mg of eletriptan, 80 mg of …
Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison.
Diener HC, Jansen JP, Reches A, Pascual J, Pitei D, Steiner TJ; Eletriptan and Cafergot Comparative Study Group. Diener HC, et al. Eur Neurol. 2002;47(2):99-107. doi: 10.1159/000047960. Eur Neurol. 2002. PMID: 11844898 Clinical Trial.

Substantially more eletriptan recipients reported no pain (80 mg, 38%; 40 mg, 28%; Cafergot, 10%; placebo, 5%; p < 0.001). ...This randomised trial shows that oral eletriptan is more efficacious in the acute treatment of migraine than oral Cafergot and is well to

…

Substantially more eletriptan recipients reported no pain (80 mg, 38%; 40 mg, 28%; Cafergot, 10%; placebo, 5%; p < 0.001). ...This

…
Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.
Goadsby PJ, Ferrari MD, Olesen J, Stovner LJ, Senard JM, Jackson NC, Poole PH. Goadsby PJ, et al. Neurology. 2000 Jan 11;54(1):156-63. doi: 10.1212/wnl.54.1.156. Neurology. 2000. PMID: 10636142 Clinical Trial.
RESULTS: At the primary endpoint (2 hours after dosing), headache response rates were 24% (30/126) for placebo; 55% (63/115) for sumatriptan, 100 mg; 54% (70/129) for eletriptan, 20 mg; 65% (76/117) for eletriptan, 40 mg; and 77% (91/118) for eletriptan, 80 m …
RESULTS: At the primary endpoint (2 hours after dosing), headache response rates were 24% (30/126) for placebo; 55% (63/115) for sumatriptan …
Pharmacokinetics, pharmacodynamics, and safety of the 5-HT(1B/1D) agonist eletriptan following intravenous and oral administration.
Milton KA, Scott NR, Allen MJ, Abel S, Jenkins VC, James GC, Rance DJ, Eve MD. Milton KA, et al. J Clin Pharmacol. 2002 May;42(5):528-39. doi: 10.1177/00912700222011580. J Clin Pharmacol. 2002. PMID: 12017347 Clinical Trial.
Eletriptan was well tolerated, and treatment-related adverse events were mild to moderate and transient. These PK properties should result in eletriptan having a rapid onset and sustained duration of action in terms of migraine efficacy....
Eletriptan was well tolerated, and treatment-related adverse events were mild to moderate and transient. These PK properties should r …
Comparative efficacy of eletriptan vs. naratriptan in the acute treatment of migraine.
Garcia-Ramos G, MacGregor EA, Hilliard B, Bordini CA, Leston J, Hettiarachchi J. Garcia-Ramos G, et al. Cephalalgia. 2003 Nov;23(9):869-76. doi: 10.1046/j.1468-2982.2003.00593.x. Cephalalgia. 2003. PMID: 14616928 Clinical Trial.

Headache response rates at 2 h and 4 h, respectively, were 56% and 80% for eletriptan, 42% and 67% for naratriptan (P < 0.01 for both time-points vs. eletriptan), and 31% and 44% for placebo (P < 0.0001 vs. both active drugs at both time-points). ...Both el

…

Headache response rates at 2 h and 4 h, respectively, were 56% and 80% for eletriptan, 42% and 67% for naratriptan (P < 0.01 for b

…
The pharmacokinetics and safety of single escalating oral doses of eletriptan.
Shah AK, Harris SC, Greenhalgh C, Morganroth J. Shah AK, et al. J Clin Pharmacol. 2002 May;42(5):520-7. doi: 10.1177/00912700222011571. J Clin Pharmacol. 2002. PMID: 12017346 Clinical Trial.
Following screening and baseline measurements, plasma and saliva eletriptan concentrations were measured at intervals over 48 hours and 24 hours, respectively. ...Eletriptan exhibited a median time to maximum plasma concentration of 1 to 1.25 hours and a mean elimin …
Following screening and baseline measurements, plasma and saliva eletriptan concentrations were measured at intervals over 48 hours a …
47 results